Dr. Neeraj Saraf

Senior Director

29 Years of Experience

HPB and Liver Transplant Surgeon, Surgical Gastroenterologist

MBBS, MD, DNB, Fellowship

Reg. No.:5079, Haryana State Medical Council

Medanta - The Medicity Hospital, Gurgaon

English

Consultation Fee ₹ 1500

Book an Appointment

About Dr. Neeraj Saraf

Dr. Neeraj Saraf is a renowned Surgical Gastroenterologist and Liver Transplant Surgeon with over 29 years of experience.
His vast expertise spans various conditions such as viral hepatitis, fatty liver, liver cirrhosis, and liver failure.
He boasts extensive experience in treating Hepatitis C, utilizing state-of-the-art direct-acting antivirals, positioning him as one of the foremost practitioners in the country for this condition.
He holds one of the most extensive records in the nation, having treated over 3000 liver transplant patients, showcasing his proficiency in managing pre- and post-transplant care.
After completing his MBBS from MP Shah Medical College, Jamnagar, in 1995, he also achieved an MD (Medicine) from RNT Medical College, Udaipur, in 1999 and a DNB (Gastroenterology) from the National Board Of Examination, 2003.
He also achieved a Fellowship in Advanced Clinical Hepatology.
Dr. Saraf is sought after globally for his guidance on liver transplantation, with patients from around the world seeking his advice.
As an active member of numerous international liver societies such as Indian Society of Gastroenterology, Indian national association for study of liver (INASL), and American Association of the Study of Liver Diseases, he contributes significantly to advancements in the field, both as a speaker and through his involvement in clinical research.

Book Your Appointment With Dr. Neeraj Saraf

Get a Treatment Plan Within 1 Hour

Name*

Mobile Number*

Is the above number on WhatsApp? *

Yes

Query

Education

MBBS, MP Shah Medical College, Jamnagar, 1995
MD (Medicine), RNT Medical College, Udaipur, 1999
DNB (Gastroenterology), National Board Of Examination, 2003
Fellowship in Advanced Clinical Hepatology

Past Experience

Consultant, Sir Ganga Ram Hospital, New Delhi, 2010
Consultant, Global Hospital, Hyderabad, 2006
Consultant, St. Stephens Hospital, Delhi, 2004

Awards

1st rank in Community Medicine (Medical School)
3rd rank in Obstetrics and Gynecology
1st prize, National Medical Quiz - 1997

Associations/Membership

Indian Society of Gastroenterology
Indian national association for the study of liver (INASL)
American Association of the Study of Liver Diseases

Paper Published

APASL clinical practice guidelines on the management of acute kidney injury in acute-on-chronic liver failure
Prevalence of Modifiable Risk Factors for de novo Malignancies After Living Donor Liver Transplantation
Transplantation Publish Ahead of Print Safe use of right lobe live donor livers with up to 20% macrovesicular steatosis without compromising donor safety and recipient outcome MELD -Model for End-Stage Liver Disease score SFS -Small for size.
Post Living Donor Liver Transplantation Small-for-size Syndrome: Definitions, Timelines, Biochemical, and Clinical Factors for Diagnosis: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference
Post-transplant Non-alcoholic Fatty Liver Disease and Metabolic Syndrome After Living Donor Liver Transplantation in Indians
Atezolizumab and Bevacizumab for Treatment of Patients With Unresectable / Non-transplantable Advanced Hepatocellular Carcinoma: A Real-World Single Center Experience from North India
Simultaneous 3-way Paired Exchange Liver Transplantation Without Nondirected Donation: Novel Strategy to Expand the Donor Pool
South Asian Transplant Infectious Disease Guidelines for Solid Organ Transplant Candidates, Recipients, and Donors
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Non-alcoholic Fatty Liver Disease (NAFLD)
Safety and Efficacy of Dual PPAR- Alpha Agonist, Saroglitazar, in Management of NAFLD with Diabetes and Dyslipidemia in Liver Transplant Recipients
Postoperative Day 7 serum creatinine and serum bilirubin levels predict mortality in living donor liver transplantation recipients with early allograft dysfunction.
Metabolic dysfunction-associated steatotic liver disease: Where does non-alcoholic fatty liver disease in liver transplant recipients fit in this new definition?
'Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Non-alcoholic Fatty Liver Disease (NAFLD)
Acute variceal bleeding portends poor outcomes in patients with acute-on-chronic liver failure: a propensity score matched study from the APASL ACLF Research Consortium (AARC)
Optimal Cut-off of Controlled Attenuation Parameter with MRI-PDFF as Reference Standard for the Detection of Liver Steatosis'
Checkpoint inhibitor-based Immunotherapy in unresectable/non-transplantable hepatocellular carcinoma: Initial experience.
Non-alcoholic fatty liver in the lean: clinical-biochemical correlates of histopathology in 157 liver biopsies from healthy liver donors
Nutrition in Chronic Liver Disease: Consensus statement of the Indian National Association for Study of the Liver (INASL
Successful Outcome of Bariatric Surgery in Living Donor Liver Transplant Recipients With Multidisciplinary Approach: A Preliminary Experience
Corrigendum to "Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data System" [J Clin Exp Hepatol 9 (2019) 625–651]
Experience With LDLT in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis Post Downstaging Do Recipients of Genetically Related Donors Have Better Outcomes After Living Donor Liver Transplantation?
Correction to: Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL): an update
Is Portal Inflow Modulation Always Necessary for Successful Utilization of Small Volume Living Donor Liver Grafts?
Joint Consensus Statement of the Indian National Association for Study of the Liver (INASL) and Indian Radiological and Imaging Association (IRIA) for the Diagnosis and Imaging of Hepatocellular Carcinoma (HCC) incorporating Liver Imaging Reporting and Data System (LIRADS).
Incidence and Mortality of Acute on Chronic Liver Failure Using Two Definitions in Patients with Compensated Cirrhosis
Factors Associated With Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver Transplantation: Unanswered Questions
Safe Use of Right Lobe Live Donor Livers With up to 20% Macrovesicular Steatosis Without Compromising Donor Safety and Recipient Outcome
Good Long Term Outcome With Low Recurrence Rate in Patients With Primary Sclerosing Cholangitis Undergoing Living Donor Liver Transplantation
Poor Performance Status Is an Independent Predictor of Mortality after Living Donor Liver Transplantation
INASL Guidelines on Management of Hepatitis B virus infection in patients receiving chemotherapy, biologicals, immunosuppressants, or corticosteroids
Outcome of living donor liver transplantation between genetically related and unrelated donors: experience of 1372 adult living donor liver transplantations from a single center
Good Outcome of Living Donor Liver Transplantation for Severe Alcoholic Hepatitis not Responding to Medical Management: a Single Center Experience of 39 Patients.
Cytomegalovirus infection in living donor liver transplant recipients significantly impacts the early post-transplant outcome: A single-center experience.
Outcome of Living Donor Liver Transplantation for Wilson's Disease in Adults: A Single-Center Experience
Diagnostic Accuracy, Safety, and Impact of Endoscopic Ultrasound Fine Needle Aspiration of Enlarged Left Adrenal in Patients With Decompensated Cirrhosis
A high MELD score does not adversely affect the Living Donor Liver Transplantation Experience outcome in 1000 recipients.
Impact of endoscopic ultrasound-guided fine-needle aspiration in prospective liver transplant recipients with hepatocellular carcinoma and lymphadenopathy
Impact and safety of endoscopic ultrasound-guided fine needle aspiration on patients with cirrhosis and pyrexia of unknown origin in India
Lower relapse rates with good post-transplant outcome in alcoholic liver disease: Experience from a living donor liver transplant center
Innovative Approach of Using Esophageal Stent for Refractory Post-Band Ligation Esophageal Ulcer Bleed Following Living Donor Liver Transplantation
Genotype 3 and higher low-density lipoprotein levels are predictors of good response to treatment of recurrent hepatitis C following living donor liver transplantation.
CMV Infection in Living Donor Liver Transplant Recipients Significantly Impacts the Early Post-Transplant Outcome: A Large Single Center Experience
Eosinophilic gastroenteritis mimicking a malignant gastric ulcer with lymphadenopathy as shown by computed tomography and endoscopic ultrasound
Low-dose short-term hepatitis B immunoglobulin with high genetic barrier antivirals: The ideal post-transplant hepatitis B virus prophylaxis?
Improving Safety of Abo-Incompatible Living Donor Liver Transplantation with a Simplified Protocol of Low-Dose Rituximab and Double-Filtration Plasmapheresis
Lower Recidivism Rates with Good Post-Transplant Outcome in Alcoholic Liver Disease: Experience from a Large Volume Living Donor Liver Transplant Center
Successful Donation After Rapid Reversal of Liver Steatosis with Lifestyle Modification in Highly Motivated Donors in Living Donor Liver Transplant Program
Genotype 3 and Higher LDL Levels are Predictors of Good Response for Hepatitis C Recurrence Post Living Donor Liver Transplantation
Preoperative Predictors of Mortality with Graft to Recipient Weight Ratio
Excellent outcome of living donor liver transplantation in patients with hepatopulmonary syndrome: A single-center experience
Low-dose short-term HBIG with high genetic barrier antivirals is associated with a Minimal Risk of Hepatitis B Recurrence after Liver Transplantation.
Non-cirrhotic portal fibrosis related end-stage liver disease in adults: Evaluation from a study on living donor liver transplant recipients
Pre-Transplant Portal Vein Thrombosis: Operative Management and Outcome in 426 Consecutive Liver Donor Liver Transplants
Development of hepatic granulomas in patients receiving pegylated interferon therapy for recurrent hepatitis C virus post liver transplantation
Etiological and clinical profile of acute hepatitis in a tertiary referral center in North India